35790892|t|Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity.
35790892|a|Glycogen synthase kinase-3beta (GSK-3beta) is an important serine/threonine kinase that implicates in multiple cellular processes and links with the neurodegenerative diseases including Alzheimer's disease (AD). In this study, structure-based virtual screening was performed to search database for compounds targeting GSK-3beta from Enamine's screening collection. Of the top-ranked compounds, 7 primary hits underwent a luminescent kinase assay and a cell assay using human neuroblastoma SH-SY5Y cells expressing Tau repeat domain (TauRD) with pro-aggregant mutation DeltaK280. In the kinase assay for these 7 compounds, residual GSK-3beta activities ranged from 36.1% to 90.0% were detected at the IC50 of SB-216763. In the cell assay, only compounds VB-030 and VB-037 reduced Tau aggregation in SH-SY5Y cells expressing DeltaK280 TauRD-DsRed folding reporter. In SH-SY5Y cells expressing DeltaK280 TauRD, neither VB-030 nor VB-037 increased expression of GSK-3alpha Ser21 or GSK-3beta Ser9. Among extracellular signal-regulated kinase (ERK), AKT serine/threonine kinase 1 (AKT), mitogen-activated protein kinase 14 (P38) and mitogen-activated protein kinase 8 (JNK) which modulate Tau phosphorylation, VB-037 attenuated active phosphorylation of P38 Thr180/Tyr182, whereas VB-030 had no effect on the phosphorylation status of ERK, AKT, P38 or JNK. However, both VB-030 and VB-037 reduced endogenous Tau phosphorylation at Ser202, Thr231, Ser396 and Ser404 in neuronally differentiated SH-SY5Y expressing DeltaK280 TauRD. In addition, VB-030 and VB-037 further improved neuronal survival and/or neurite length and branch in mouse hippocampal primary culture under Tau cytotoxicity. Overall, through inhibiting GSK-3beta kinase activity and/or p-P38 (Thr180/Tyr182), both compounds may serve as promising candidates to reduce Tau aggregation/cytotoxicity for AD treatment.
35790892	56	61	Human	Species	9606
35790892	62	69	SH-SY5Y	CellLine	CVCL:0019
35790892	87	90	Tau	Gene	4137
35790892	112	117	Mouse	Species	10090
35790892	170	200	Glycogen synthase kinase-3beta	Gene	2932
35790892	202	211	GSK-3beta	Gene	2932
35790892	319	345	neurodegenerative diseases	Disease	MESH:D019636
35790892	356	375	Alzheimer's disease	Disease	MESH:D000544
35790892	377	379	AD	Disease	MESH:D000544
35790892	488	497	GSK-3beta	Gene	2932
35790892	503	510	Enamine	Chemical	-
35790892	639	644	human	Species	9606
35790892	645	658	neuroblastoma	Disease	MESH:D009447
35790892	659	666	SH-SY5Y	CellLine	CVCL:0019
35790892	684	687	Tau	Gene	4137
35790892	801	810	GSK-3beta	Gene	2932
35790892	878	887	SB-216763	Chemical	MESH:C417521
35790892	923	929	VB-030	Chemical	-
35790892	934	940	VB-037	Chemical	-
35790892	968	975	SH-SY5Y	CellLine	CVCL:0019
35790892	1036	1043	SH-SY5Y	CellLine	CVCL:0019
35790892	1086	1092	VB-030	Chemical	-
35790892	1097	1103	VB-037	Chemical	-
35790892	1128	1138	GSK-3alpha	Gene	2931
35790892	1148	1157	GSK-3beta	Gene	2932
35790892	1170	1207	extracellular signal-regulated kinase	Gene	5594
35790892	1209	1212	ERK	Gene	5594
35790892	1215	1244	AKT serine/threonine kinase 1	Gene	207
35790892	1246	1249	AKT	Gene	207
35790892	1252	1287	mitogen-activated protein kinase 14	Gene	1432
35790892	1289	1292	P38	Gene	1432
35790892	1298	1332	mitogen-activated protein kinase 8	Gene	26419
35790892	1334	1337	JNK	Gene	5599
35790892	1354	1357	Tau	Gene	4137
35790892	1375	1381	VB-037	Chemical	-
35790892	1419	1422	P38	Gene	26416
35790892	1446	1452	VB-030	Chemical	-
35790892	1500	1503	ERK	Gene	5594
35790892	1505	1508	AKT	Gene	11651
35790892	1510	1513	P38	Gene	26416
35790892	1517	1520	JNK	Gene	26419
35790892	1536	1542	VB-030	Chemical	-
35790892	1547	1553	VB-037	Chemical	-
35790892	1573	1576	Tau	Gene	4137
35790892	1659	1666	SH-SY5Y	CellLine	CVCL:0019
35790892	1708	1714	VB-030	Chemical	-
35790892	1719	1725	VB-037	Chemical	-
35790892	1797	1802	mouse	Species	10090
35790892	2014	2026	cytotoxicity	Disease	MESH:D064420
35790892	2031	2033	AD	Disease	MESH:D000544
35790892	Association	MESH:D000544	2932
35790892	Association	MESH:D009447	4137
35790892	Negative_Correlation	MESH:C417521	2932
35790892	Association	4137	5594
35790892	Association	26419	4137
35790892	Association	4137	5599
35790892	Association	1432	4137
35790892	Association	MESH:D019636	2932
35790892	Association	207	4137

